RI
CHRS icon

Redwood Investments’s Coherus Oncology CHRS Stock Holding History

Redwood Investments’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-709,184
Closed -$11.3M – 131
2021
Q4 		$11.3M Sell
709,184
-7,347
-1% -$128K 0.89% 45
2021
Q3 		$11.5M Sell
716,531
-44,717
-6% -$655K 0.96% 49
2021
Q2 		$10.5M Sell
761,248
-4
-0% -$57 0.85% 51
2021
Q1 		$11.1M Sell
761,252
-123,275
-14% -$2.09M 0.98% 47
2020
Q4 		$15.4M Buy
884,527
+39,701
+5% +$707K 1.31% 33
2020
Q3 		$15.5M Sell
844,826
-49,352
-6% -$918K 1.31% 32
2020
Q2 		$16M Buy
+894,178
New +$15.1M 1.41% 29

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Redwood Investments's CHRS Position: Q1 2022 in Review

Redwood Investments sold out of Coherus Oncology (CHRS) in Q1 2022, closing a stake of 709,184 shares — an estimated $11.3M sold.

Redwood Investments first reported a position in CHRS in Q2 2020 and held it in 7 quarters. The position peaked at $16M in Q2 2020. 183 funds tracked by Wall St. Rank hold CHRS as of Q1 2022.

  • Redwood Investments reported no remaining Coherus Oncology position as of Q1 2022 after selling out during the quarter.
  • Redwood Investments sold 709,184 Coherus Oncology shares in Q1 2022, an estimated $11.3M.
  • Redwood Investments first reported a position in Coherus Oncology in Q2 2020 and held it in 7 quarters.
  • Redwood Investments's Coherus Oncology position peaked at $16M in Q2 2020.
  • 183 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2022.

Based on Redwood Investments's 13F filing for Q1 2022, filed 20 Apr 2022.